4,490
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Tackling metastatic triple-negative breast cancer with sacituzumab govitecan

ORCID Icon, &
Pages 1303-1311 | Received 08 Sep 2021, Accepted 11 Oct 2021, Published online: 22 Oct 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.